YICHANG, China, Nov. 4, 2025 /PRNewswire/ — Angel Yeast Co., Ltd. (SH600298) has officially started operations at its next-generation yeast protein production line at the Baiyang Biotechnology Park in Yichang, Hubei. The facility has an annual production capacity of 11,000 tons of high-purity yeast protein with a protein content exceeding 80%. This marks a key… Continue reading Angel Yeast starts Operating New 11,000-Ton Yeast Protein Production Line to Meet Global Demand for Sustainable Nutrition
Tag: Manufacturing
Rosen Law Firm Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation – HRL
NEW YORK, Nov. 4, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hormel Foods Corporation (NYSE: HRL) resulting from allegations that Hormel may have issued materially misleading business information to the investing public. So What: If you purchased Hormel… Continue reading Rosen Law Firm Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation – HRL
A look into the past, a ride into the future: Bosch celebrates three decades of Motorcycle ABS safety
Bosch’s work on motorcycle ABS began in 1986, building on passenger-car technology that was launched in 1978, and culminated in the first production motorcycle equipped with Bosch ABS in 1995, the Kawasaki GPZ1100 ABS. The company’s sustained commitment led to the establishment of a center of competence for two-wheeler safety technology in Japan in 2007,… Continue reading A look into the past, a ride into the future: Bosch celebrates three decades of Motorcycle ABS safety
JSPR Deadline: JSPR Investors with Losses in Excess of $100K Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, Nov. 4, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline. So what: If you purchased Jasper… Continue reading JSPR Deadline: JSPR Investors with Losses in Excess of $100K Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
RAMACO RESOURCES, INC. ANNOUNCES PROPOSED OFFERING OF BORROWED CLASS A COMMON STOCK TO FACILITATE HEDGING TRANSACTIONS
LEXINGTON, Ky., Nov. 4, 2025 /PRNewswire/ — Ramaco Resources, Inc. (NASDAQ: METC) (“Ramaco” or the “Company”) announced today, in a separate press release, its intention to offer, in an underwritten public offering, subject to market and other conditions, $300,000,000 aggregate principal amount of convertible senior notes due 2031 (the “notes”), plus up to an additional… Continue reading RAMACO RESOURCES, INC. ANNOUNCES PROPOSED OFFERING OF BORROWED CLASS A COMMON STOCK TO FACILITATE HEDGING TRANSACTIONS
CPTN INVESTOR ALERT: Berger Montague Advises Cepton, Inc. (NASDAQ: CPTN) Investors of a December 8, 2025 Deadline
PHILADELPHIA, Nov. 4, 2025 /PRNewswire/ — National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Cepton, Inc. (NASDAQ: CPTN) (“Cepton” or the “Company”) on behalf of investors who purchased or sold Cepton shares during the period of July 29, 2024 through January 6, 2025 (the “Class Period”). Investor Deadline: Investors who purchased or sold… Continue reading CPTN INVESTOR ALERT: Berger Montague Advises Cepton, Inc. (NASDAQ: CPTN) Investors of a December 8, 2025 Deadline
Ovintiv Reports Third Quarter 2025 Financial and Operating Results
Full Year Production Guidance Increased, Capital Investment Unchanged Highlights: Generated cash from operating activities of $812 million, Non-GAAP Cash Flow of $895 million and Non-GAAP Free Cash Flow of $351 million after capital expenditures of $544 million Third quarter production was at or above the high end of the guidance range on every product with… Continue reading Ovintiv Reports Third Quarter 2025 Financial and Operating Results
CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH
NASHVILLE, Tenn., Nov. 4, 2025 /PRNewswire/ — Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined net revenues of $8.3 million during the third quarter of 2025. Year-to-date revenues for the first nine months of the year totaled $30.8 million, representing an increase of… Continue reading CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH
Ovintiv Completes Portfolio Transformation with Agreement to Acquire NuVista Energy Ltd. and Planned Divestiture of Anadarko Assets
Transaction Adds Scale and High-Quality Oil Inventory to Ovintiv’s Premier Montney Position Highlights: Agreement reached to acquire NuVista Energy Ltd. at an average price of approximately C$17.80 per share, or total consideration of approximately $2.7 billion (C$3.8 billion) Acquisition is expected to add approximately 140,000 net acres and approximately 100 thousand barrels of oil equivalent… Continue reading Ovintiv Completes Portfolio Transformation with Agreement to Acquire NuVista Energy Ltd. and Planned Divestiture of Anadarko Assets
Tesla stock used to help employees. Now it can’t, because Elon took it all.
Tesla shareholders will decide whether to give CEO Elon Musk a stock award that could be worth up to $1 trillion. But another proposal is up for a vote to refill Tesla’s employee stock option pool, and it’s only necessary because that pool was drained to give Musk a payday larger than any other CEO… Continue reading Tesla stock used to help employees. Now it can’t, because Elon took it all.